Heterophile Antibody Interference in a Multiplexed Fluorescent Microsphere Immunoassay for Quantitation of Cytokines in Human Serum
Overview
Affiliations
While modern immunoassays provide sensitive and specific means for the quantitation of cytokines in biological fluids, heterophile antibodies are still a well-recognized cause of interference in the measurement of cytokines in these assays. We have developed a multiplexed fluorescent microsphere immunoassay for the simultaneous quantification of 10 cytokines in only 75 microl of serum. During the development of this multiplexed assay, the amount of assay interference due to heterophile antibodies was also determined, and methods for detecting heterophile interference and minimizing its effect were incorporated into the assay. Heterophile antibodies resulted in significantly elevated cytokine values compared to those of normal blood bank samples. These falsely elevated values, and thus the components of the assay the heterophile antibodies were binding to, were identified through the use of internal controls. This information was then used to design assay-specific blockers and absorbents that were shown to significantly reduce falsely elevated cytokine values while not affecting the standard and control values. The fluorescent multiplexed microsphere-based immunoassay can be used to quantitate multiple cytokines from a single sample and should be a useful tool in furthering our understanding of the role of cytokines in disease processes.
Shang J, Yan M, Zhang X, Liu W, Wu S, Wang Z BMC Biotechnol. 2024; 24(1):65.
PMID: 39333983 PMC: 11429854. DOI: 10.1186/s12896-024-00900-2.
Cytokine Deficiencies in Patients with Long-COVID.
Williams E, Martins T, Shah K, Hill H, Coiras M, Spivak A J Clin Cell Immunol. 2023; 13(6).
PMID: 36742994 PMC: 9894377.
van Santen S, Out J, Zoutman W, Quint K, Willemze R, Vermeer M Biochem Biophys Rep. 2021; 26:101007.
PMID: 34027133 PMC: 8121649. DOI: 10.1016/j.bbrep.2021.101007.
Liu B, Martins T, Peterson L, Hill H Cytokine. 2021; 142:155478.
PMID: 33667962 PMC: 7901304. DOI: 10.1016/j.cyto.2021.155478.
Severe SARS-CoV-2 disease in the context of a NF-κB2 loss-of-function pathogenic variant.
Abraham R, Marshall J, Kuehn H, Rueda C, Gibbs A, Guider W J Allergy Clin Immunol. 2020; 147(2):532-544.e1.
PMID: 33007327 PMC: 7525247. DOI: 10.1016/j.jaci.2020.09.020.